Clinical Trials Directory

Insulin Resistance Intervention After Stroke (IRIS) Trial

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Stanford is now accepting new patients for this trial.

Investigator(s):

Intervention(s):

  • drug : placebo
  • drug : pioglitazone

Phase: Phase 3

Eligibility

Ages Eligible For Study:

40 Years - N/A

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Madelleine Garcia
6507252326
Recruiting

Footer Links: